FK506 causes cellular and functional defects in human natural killer cells

Journal of Leukocyte Biology
Tae-Jin KimKyung-Mi Lee


The role of NK cells in allogeneic HCT has been increasingly appreciated, particularly in the GVL effect. Although FK506 has been used widely to prevent GVHD, its action was considered to be primarily through activated T cells. In this study, we provide direct evidence for the first time that human NK cells are immediate targets of FK506. Our in vivo data from patients undergoing peripheral blood stem cell transplantation or BMT showed a reduced number of NK cells with down-regulated CD25 expression in their peripheral blood compartment. Likewise, FK506 caused profound inhibition of NK cell proliferation in vitro and suppressed NK cytotoxicity and cytokine secretion in response to IL-2. These defects were accompanied by impaired cell clustering and selective down-regulation of adhesion molecules, ICAM-1, CD2, CD49d, and CD58. Furthermore, FK506 specifically inhibited expression of NKG2D, CD48, and DNAM1 receptors without affecting that of 2B4, NKp30, NKp44, and NKp46. As a result, natural cytotoxicity against K562 tumor targets was impaired, while leaving redirected ADCC via 2B4 intact. Finally, FK506-treated NK cells showed impaired IL-2R signaling and inhibition of STAT3. Collectively, these signaling impairments and selectiv...Continue Reading


Jul 21, 1997·The Journal of Experimental Medicine·X C LiaoD R Littman
Dec 23, 1998·European Journal of Immunology·Y Latchman, H Reiser
Aug 18, 2001·Bone Marrow Transplantation·A HiraokaUNKNOWN Japanese FK506 BMT(Bone Marrow Transplantation) Study Group
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Domingo F Barber, Eric O Long
Jul 30, 2003·Journal of Leukocyte Biology·Jennifer A ToomeyColin G Brooks
Oct 8, 2003·The Journal of Experimental Medicine·Daniel B StetsonRichard M Locksley
Dec 18, 2004·Journal of Immunological Methods·Galit AlterMarcus Altfeld
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alessandro PoggiMaria Raffaella Zocchi
Nov 30, 2006·Annual Review of Immunology·Lisbeth A WelniakWilliam J Murphy
Oct 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Young-Hee LeeChong-Kil Lee
Dec 11, 2007·The Journal of Biological Chemistry·Marylynn SnyderJ Jillian Zhang
Mar 4, 2008·Expert Opinion on Pharmacotherapy·Lyndsey J Bowman, Daniel C Brennan
Sep 3, 2008·Cellular Immunology·Arun T Pores-FernandoAdam Zweifach

❮ Previous
Next ❯


Feb 7, 2013·Journal of Cancer·Jeanne M PalmerSubramaniam Malarkannan
Jul 9, 2013·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·M GubaC Bruns
May 23, 2012·Blood·Jan FricPaola Ricciardi-Castagnoli
Aug 17, 2010·Developmental Cell·Marina BershteynAnthony E Oro
Aug 18, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·S KanameishiK Kabashima
Dec 7, 2010·Developmental Biology·Andrew M Ravanelli, John Klingensmith
Feb 8, 2018·Journal of Immunology Research·Gisella Puga YungJörg D Seebach
May 3, 2019·Therapeutic Drug Monitoring·Mercè BrunetStein Bergan
Nov 17, 2020·Frontiers in Immunology·Yue WuQiang Xia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.